Pigment Epithelium-Derived Factor (PEDF): Its Potential Therapeutic Implication in Diabetic Vascular Complications

E-ISSN： 1873-5592|9|11|1025-1029

ISSN： 1389-4501

Source： Current Drug Targets, Vol.9, Iss.11, 2008-11, pp. : 1025-1029

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease

By Rychli Kathrin Huber Kurt Wojta Johann

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 11, 2009-11 ,pp. : 1295-1302

Informa Healthcare

Access to resources Recommend Favorite

Pigment Epithelium-derived Factor (PEDF) and Cardiometabolic Disorders

Current Pharmaceutical Design, Vol. 20, Iss. 14, 2014-04 ,pp. : 2377-2386

Bentham Science Publishers

Access to resources Recommend Favorite

Atheroprotective Properties of Pigment Epithelium-Derived Factor (PEDF) in Cardiometabolic Disorders

Current Pharmaceutical Design, Vol. 15, Iss. 9, 2009-03 ,pp. : 1027-1033

Bentham Science Publishers

Access to resources Recommend Favorite

Pathophysiological Role of Pigment Epithelium-Derived Factor (PEDF) in Hepatic Disorders

Current Medicinal Chemistry, Vol. 17, Iss. 19, 2010-07 ,pp. : 1995-2000

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Pigment Epithelium-Derived Factor (PEDF) Augments Vascular Endothelial Growth Factor (VEGF)-Induced Recovery of Limb Perfusion after Ischemia in Klotho Mouse

Letters in Drug Design & Discovery, Vol. 7, Iss. 7, 2010-08 ,pp. : 541-545

Bentham Science Publishers

Access to resources Recommend Favorite